There is no excerpt because this is a protected post.
Author: bm-jcc
Continuous bevacizumab plus second line chemotherapy beyond progression during or after maintenance bevacizumab
http://dx.doi.org/10.18081/jcc/016-06/12-23 Journal of Cellular Cancer Volume 8, Issue 1, pages 12-23 Received January 28, 2016; accepted May 21, 2016; published June 17, 2016 Haider Y. Shukur1* Abstract Bevacizumab has FDA approval in the first and second line treatment combined with chemotherapy of epithelial ovarian cancer (EOC). Data is lacking on survival outcomes in patients who…
Male breast tumors and oxidative DNA damage
Open Access http://dx.doi.org/10.18081/jcc/016-06/1-8 Journal of Cellular Cancer Volume 8, Issue 1, pages 1-8 Received December 23, 2015; accepted May 12, 2016; published June 11, 2016 Estabraq AR. Al-Wasiti* Abstract Male breast cancer is a rare compared to its female counterpart and makes less than 1% of all breast cancer. Risk factors for breast cancer in…
Critical role of BIRC5 amplification in gastric cancer
http://dx.doi.org/10.18081/jcc/016-06/1-15 Journal of Cellular Cancer Volume 8, Issue 1, pages 16-22 Received December 02, 2015; accepted May 20, 2016; published June 13, 2016 Lianghai Zuo1, Jing Wang 2, Feng Xiong1, Jun Hou1* Abstract Baculoviral IAP repeats containing 5 (BIRC5) is negatively encoded proteins regulation and inhibit apoptosis. BIRC5 has been demonstrated to…
Protected:
There is no excerpt because this is a protected post.
Histological implication of p53 gene expression in oral squamous cell carcinoma
Karima Al Salihi1*, Ihsan Abdullah2, S. L. Ang3 Author Affiliations *Corresponding Author: Electronic address: mrvsa59@gmail.com. ¹College of Veterinary Medicine/Al Muthanna University. ²College of dentistry/Al Muthanna University. ³School of Dental Sciences/ University Science Malaysia/ Malaysia Abstract This study intends to detect the TP53 genetic alterations and mutations in the conserved regions of the TP53…
STAT3 suppress the proliferation and invasion of ovarian cancer cells via IL-37 expression
Research Article Journal of Cellular Cancer Volume 7, Issue 1, pages 43-56 Published: June 22, 2015 Mark Fullerton, Lihua Li, Ling Wu, David B. Mulier, Xian Chen, Celeste B. Determan, Jean Friese, Ling Yao Abstract Most ovarian cancers are highly invasive and the high burden of metastatic disease make them a leading cause of mortality…
Overexpression of Protein tyrosine kinase 6 enhances apoptosis of trastuzumab-resistant Her2 + breast cancer cells
Journal of Cellular Cancer Volume 6, Issue 2, pages 72-88 Published: December 28, 2014 Susan N. Sparano, Hyman Cirrincione, Nasser Ghaly Yousif, Michael Davidson, Jeffrey A. Louie, Dan G. Wang, Alexey F Maltzman, Howell G Johnston, Aman S Gomez, Han Lee Abstract Overexpression of protein tyrosine kinase 6 (PTK6) enhances proliferation, and migration…
ERK2 deregulates of β-catenin in esophageal cancer via CSN6
Research Article Journal of Cellular Cancer Volume 7, Issue 1, pages 30-42 Published: June 20, 2015 Lijun Fang, Chuangqi Qiong, Xiaofeng Xia, Liang Shijun, Gentao Lei, Jung-Yu Yang Abstract The extracellular-signal-regulated-kinase (ERK) signaling pathway is frequently deregulated in tumors.The objective of this study is to investigate the association between ERK2/β-catenin in risk of esophageal…
Critical relationship between neutrophil/lymphocyte ratio with overall survival breast cancer
Research Article Journal of Cellular Cancer Volume 7, Issue 1, pages 17-29 Published: June 12, 2015 Philippe Kainuma, Yannick Yamamoto, Nobuhiro Takiguchi, Kimberly Rzymkiewicz, Jean-François Eduardo Abstract The immune response to various physiological challenges is characterized by increased neutrophil and decreased lymphocyte counts, and NLR is often recognized as an inflammatory marker to…